Skip to main content

Select Drug Profiles

Pancreatic Cancer, Oncology

Practice-Changing Results: Olaparib Maintenance Therapy Extends Progression-Free Survival in Metastatic Pancreatic Cancer with Germline BRCA Mutation

Phoebe Starr

Breast Cancer, Oncology

MONALEESA-7 Sets New Standard of Care for Premenopausal Advanced Breast Cancer: Adding CDK4/6 to Endocrine Therapy Extends Survival

Phoebe Starr

Darzalex Combined with Revlimid and Dexamethasone New First-Line Regimen for Patients with Multiple Myeloma Ineligible for Transplant

Keytruda Receives New Indication for Metastatic Small-Cell Lung Cancer After Disease Progression

Keytruda First PD-1 Inhibitor Approved as First-Line Monotherapy for Patients with Metastatic or Unresectable Head and Neck Cancer

Revlimid Approved for Patients with Follicular Lymphoma or Marginal-Zone Lymphoma

Xpovio Receives FDA Approval for Patients with Relapsed or Refractory Multiple Myeloma

Polivy FDA Approved for Patients with Relapsed or Refractory DLBCL

Prostate Cancer

Enzalutamide or Apalutamide Added to ADT Improves Outcomes in Hormone-Sensitive Prostate Cancer

Phoebe Starr

Disparities in Oncology, Oncology

Access to Health Insurance Reduces Disparities in Cancer Care: The Case for the ACA

Phoebe Starr

Page 48 of 244
Results 471 - 480 of 2438